Evaluating biomarkers to predict outcomes in sepsis patients
Value of Laboratory Biomarkers in Prediction of Outcome in Septic Patients
This study is testing if certain blood markers can help doctors predict how well patients with sepsis will do, especially in places with limited resources.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | Egymedicalpedia Industry-sponsored |
| Locations | 1 site (Asyut) |
| Trial ID | NCT06338124 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the value of various laboratory biomarkers in predicting outcomes for patients diagnosed with sepsis. It focuses on both established and novel biomarkers, including the Triglyceride-glucose index, Red blood cell distribution width, C-reactive protein, and Neutrophil-lymphocyte ratio. The study seeks to identify cost-effective and accessible biomarkers that can improve risk prediction and monitoring in sepsis, particularly in low- and middle-income countries. By analyzing these biomarkers, the research hopes to enhance understanding of sepsis prognosis and potentially improve patient management.
Who should consider this trial
Good fit: Ideal candidates for this study are adults diagnosed with sepsis.
Not a fit: Patients with hematological diseases or those who refuse to participate will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more accurate and accessible methods for predicting outcomes in sepsis patients, ultimately improving patient care.
How similar studies have performed: Previous studies have shown promise in using biomarkers for sepsis prediction, but this approach focuses on novel and cost-effective options, making it a potentially innovative contribution.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: \- patients whom will be diagnosed with sepsis Exclusion Criteria: * patients diagnosed by hematological disease * patients refused to participate in the research * patients less than 18 years
Where this trial is running
Asyut
- Assuit University Hospital — Asyut, Egypt (Recruiting)
Study contacts
- Study coordinator: David Ibrahim, MSc Student
- Email: davidibrahimfarag@gmail.com
- Phone: +201063734732
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.